Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Michl

Showing results (31-40 of 151) with videos related to

Pageof 16
Sort By:
British Journal of Cancer|August 24, 2023
Anti-angiogenic therapy using the multi-tyrosine kinase inhibitor Regorafenib enhances tumor progression in a transgenic mouse model of ß-cell carcinogenesisMaren Juliane Egidi, Sebastian Krug, Johannes Haybaeck, et al.
The American Journal of Gastroenterology|February 23, 2018
Severe Colitis After an Alcohol EnemaJonas Rosendahl, Patrick Michl, Jörg Kleeff, et al.
Inflammatory Bowel Diseases|July 16, 2008
Glatiramer acetate: a novel therapeutic approach in Crohn's disease?Albrecht Neesse, Patrick Michl, Steffen Kunsch, et al.
Zeitschrift Fur Gastroenterologie|March 18, 2021
Family planning with inflammatory bowel disease: the challenge of childlessness and parent concernsJens Walldorf, Emilia Pijan, Robin Greinert, et al.
BMC Cancer|April 18, 2019
Brain metastases in patients with neuroendocrine neoplasms: risk factors and outcomeSebastian Krug, Freya Teupe, Patrick Michl, et al.
Oncotargets and Therapy|January 1, 2014
Emerging concepts in pancreatic cancer medicine: targeting the tumor stromaAlbrecht Neesse, Sebastian Krug, Thomas M Gress, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
Case Report: Rapid resolution of fever after initiation of third-line rescue treatment with upadacitinib for acute severe ulcerative colitis in two young menDan Pinzaru, Martin Kreysing, Tony Lesmeister, et al.
BMC Infectious Diseases|June 4, 2026
Clinical characteristics and outcomes of invasive fungal infections in critically ill patients with liver cirrhosisJessica Seeßle, Elena Pelivan, Marietta Kirchner, et al.
Cancer Reports (Hoboken, N.J.)|July 26, 2021
The impact of atezolizumab and bevacizumab in hepatocellular carcinoma with activated ß-catenin signalingSebastian Krug, Laura Mattheis, Monika Haemmerle, et al.
Cancer Medicine|September 19, 2025
Trends in the Treatment and Survival of Pancreatic Cancer: Analysis of 23,339 Patients Diagnosed Between 2010 and 2017Marko Damm, Miriam Heinig, Jonas Rosendahl, et al.
Pageof 16

Showing results (31-40 of 151) with videos related to

Sort By:
Pageof 16
British Journal of Cancer|August 24, 2023
Anti-angiogenic therapy using the multi-tyrosine kinase inhibitor Regorafenib enhances tumor progression in a transgenic mouse model of ß-cell carcinogenesisMaren Juliane Egidi, Sebastian Krug, Johannes Haybaeck, et al.
The American Journal of Gastroenterology|February 23, 2018
Severe Colitis After an Alcohol EnemaJonas Rosendahl, Patrick Michl, Jörg Kleeff, et al.
Inflammatory Bowel Diseases|July 16, 2008
Glatiramer acetate: a novel therapeutic approach in Crohn's disease?Albrecht Neesse, Patrick Michl, Steffen Kunsch, et al.
Zeitschrift Fur Gastroenterologie|March 18, 2021
Family planning with inflammatory bowel disease: the challenge of childlessness and parent concernsJens Walldorf, Emilia Pijan, Robin Greinert, et al.
BMC Cancer|April 18, 2019
Brain metastases in patients with neuroendocrine neoplasms: risk factors and outcomeSebastian Krug, Freya Teupe, Patrick Michl, et al.
Oncotargets and Therapy|January 1, 2014
Emerging concepts in pancreatic cancer medicine: targeting the tumor stromaAlbrecht Neesse, Sebastian Krug, Thomas M Gress, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
Case Report: Rapid resolution of fever after initiation of third-line rescue treatment with upadacitinib for acute severe ulcerative colitis in two young menDan Pinzaru, Martin Kreysing, Tony Lesmeister, et al.
BMC Infectious Diseases|June 4, 2026
Clinical characteristics and outcomes of invasive fungal infections in critically ill patients with liver cirrhosisJessica Seeßle, Elena Pelivan, Marietta Kirchner, et al.
Cancer Reports (Hoboken, N.J.)|July 26, 2021
The impact of atezolizumab and bevacizumab in hepatocellular carcinoma with activated ß-catenin signalingSebastian Krug, Laura Mattheis, Monika Haemmerle, et al.
Cancer Medicine|September 19, 2025
Trends in the Treatment and Survival of Pancreatic Cancer: Analysis of 23,339 Patients Diagnosed Between 2010 and 2017Marko Damm, Miriam Heinig, Jonas Rosendahl, et al.
Pageof 16